ESR1 and breast carcinoma: In preclinical studies, androgens exhibit antiproliferative, proapoptotic effects in ER positive breast cancer cell lines.249 Androgen receptor agonists antagonize estrogen-stimulated tumor growth, and androgen receptor expression is associated with improved disease-free survival in patients with ER positive breast cancer.169,249,250